Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus J Drake

Showing results (31-40 of 221) with videos related to

Pageof 23
Sort By:
F1000Research|February 27, 2016
Overactive bladderKaren M Wallace, Marcus J Drake
Current Opinion in Urology|November 12, 2015
Undiagnosed neurological disease as a potential cause of male lower urinary tract symptomsDiana Y Wei, Marcus J Drake
European Urology|March 27, 2024
Re: EV-301 Long-term Outcomes: 24-month Findings from the Phase III Trial of Enfortumab Vedotin Versus Chemotherapy in Patients with Previously Treated Advanced Urothelial CarcinomaMarcus J Drake, Lori A Birder
Nature Reviews. Urology|October 9, 2010
Management of overactive bladderDev M Gulur, Marcus J Drake
Neurourology and Urodynamics|January 8, 2019
Neurological lower urinary tract dysfunction essential terminologyJerzy B Gajewski, Marcus J Drake
Investigative and Clinical Urology|December 28, 2017
Definition and symptoms of underactive bladderAlan D Uren, Marcus J Drake
Current Urology Reports|October 25, 2008
Botulinum toxin treatment for overactive bladder: risk of urinary retentionAhmed M Shaban, Marcus J Drake
Current Opinion in Urology|March 13, 2018
The role of urodynamics in the surgical management of benign prostatic obstructionMatthew G Crockett, Marcus J Drake
European Urology Focus|September 5, 2024
The Urinary Microbiome Is a Potential Driver of Urinary Tract Pathology Through Multiple Mechanisms Including Deglucuronidation and DNA DamageJulian R Marchesi, Marcus J Drake
Neurourology and Urodynamics|February 2, 2011
Urinary diaries: evidence for the development and validation of diary content, format, and durationElizabeth Bright, Marcus J Drake, Paul Abrams
Pageof 23

Showing results (31-40 of 221) with videos related to

Sort By:
Pageof 23
F1000Research|February 27, 2016
Overactive bladderKaren M Wallace, Marcus J Drake
Current Opinion in Urology|November 12, 2015
Undiagnosed neurological disease as a potential cause of male lower urinary tract symptomsDiana Y Wei, Marcus J Drake
European Urology|March 27, 2024
Re: EV-301 Long-term Outcomes: 24-month Findings from the Phase III Trial of Enfortumab Vedotin Versus Chemotherapy in Patients with Previously Treated Advanced Urothelial CarcinomaMarcus J Drake, Lori A Birder
Nature Reviews. Urology|October 9, 2010
Management of overactive bladderDev M Gulur, Marcus J Drake
Neurourology and Urodynamics|January 8, 2019
Neurological lower urinary tract dysfunction essential terminologyJerzy B Gajewski, Marcus J Drake
Investigative and Clinical Urology|December 28, 2017
Definition and symptoms of underactive bladderAlan D Uren, Marcus J Drake
Current Urology Reports|October 25, 2008
Botulinum toxin treatment for overactive bladder: risk of urinary retentionAhmed M Shaban, Marcus J Drake
Current Opinion in Urology|March 13, 2018
The role of urodynamics in the surgical management of benign prostatic obstructionMatthew G Crockett, Marcus J Drake
European Urology Focus|September 5, 2024
The Urinary Microbiome Is a Potential Driver of Urinary Tract Pathology Through Multiple Mechanisms Including Deglucuronidation and DNA DamageJulian R Marchesi, Marcus J Drake
Neurourology and Urodynamics|February 2, 2011
Urinary diaries: evidence for the development and validation of diary content, format, and durationElizabeth Bright, Marcus J Drake, Paul Abrams
Pageof 23